Drug Type Bispecific antibody |
Synonyms- |
Target |
Action inhibitors |
Mechanism BMP2 inhibitors(Bone morphogenetic protein 2 inhibitors), BMP4 inhibitors(bone morphogenetic protein 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Barrett Esophagus | Preclinical | Switzerland | 10 Jan 2022 |






